BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 12917690)

  • 1. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.
    Brummelkamp TR; Nijman SM; Dirac AM; Bernards R
    Nature; 2003 Aug; 424(6950):797-801. PubMed ID: 12917690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.
    Kovalenko A; Chable-Bessia C; Cantarella G; Israël A; Wallach D; Courtois G
    Nature; 2003 Aug; 424(6950):801-5. PubMed ID: 12917691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
    Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
    Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.
    Jono H; Lim JH; Chen LF; Xu H; Trompouki E; Pan ZK; Mosialos G; Li JD
    J Biol Chem; 2004 Aug; 279(35):36171-4. PubMed ID: 15226292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation.
    Reiley W; Zhang M; Wu X; Granger E; Sun SC
    Mol Cell Biol; 2005 May; 25(10):3886-95. PubMed ID: 15870263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
    Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
    Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of JNK signaling by the tumor suppressor CYLD.
    Reiley W; Zhang M; Sun SC
    J Biol Chem; 2004 Dec; 279(53):55161-7. PubMed ID: 15496400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CYLD, NF-kappaB and NF-kappaB-related factors in salivary gland tumors.
    Fukuda M; Fukuda F; Horiuchi Y; Oku Y; Suzuki S; Kusama K; Sakashita H
    In Vivo; 2006; 20(4):467-72. PubMed ID: 16900776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis.
    Zhao Y; Ma CA; Wu L; Iwai K; Ashwell JD; Oltz EM; Ballard DW; Jain A
    J Biol Chem; 2015 Sep; 290(36):22076-84. PubMed ID: 26224629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
    Wu CJ; Conze DB; Li T; Srinivasula SM; Ashwell JD
    Nat Cell Biol; 2006 Apr; 8(4):398-406. PubMed ID: 16547522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha.
    Tang ED; Wang CY; Xiong Y; Guan KL
    J Biol Chem; 2003 Sep; 278(39):37297-305. PubMed ID: 12867425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of CYLD might be associated with development of salivary gland tumors.
    Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
    Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
    Sun SC
    Cell Death Differ; 2010 Jan; 17(1):25-34. PubMed ID: 19373246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF.
    Devin A; Lin Y; Yamaoka S; Li Z; Karin M; Liu Zg
    Mol Cell Biol; 2001 Jun; 21(12):3986-94. PubMed ID: 11359906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin signalling in the NF-kappaB pathway.
    Chen ZJ
    Nat Cell Biol; 2005 Aug; 7(8):758-65. PubMed ID: 16056267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction: aspirin, ubiquitin and cancer.
    Wilkinson KD
    Nature; 2003 Aug; 424(6950):738-9. PubMed ID: 12917671
    [No Abstract]   [Full Text] [Related]  

  • 18. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
    Roussel RR; Barchowsky A
    Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGLN3 inhibition of NF-κB is mediated by prolyl hydroxylase-independent inhibition of IκB kinase γ ubiquitination.
    Fu J; Taubman MB
    Mol Cell Biol; 2013 Aug; 33(15):3050-61. PubMed ID: 23732909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus core protein potentiates TNF-alpha-induced NF-kappaB activation through TRAF2-IKKbeta-dependent pathway.
    Chung YM; Park KJ; Choi SY; Hwang SB; Lee SY
    Biochem Biophys Res Commun; 2001 Jun; 284(1):15-9. PubMed ID: 11374864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.